Cannabis users face substantially higher risk of heart attack (2025)

Study design, confounders, and limits

• Many commenters question the value of a retrospective EMR-based study and a meta-analysis for inferring causation.
• Concerns: lack of data on dose, frequency, and route of administration (ROA); incomplete control for tobacco, other drugs, and broader lifestyle factors (stress, income, existing conditions).
• Others point out that at least one of the cited studies explicitly excluded tobacco users and major cardiac comorbidities, and controlled for some confounders.
• General consensus: associations are concerning, but results should motivate better prospective studies rather than definitive claims.

Mechanisms and physiological effects

• Several comments note that THC increases heart rate and alters blood pressure; some link this to CB1 receptor activation and sympathetic nervous system effects.
• Debate over whether transient increases in heart rate/BP are inherently harmful, with comparisons to exercise and sauna use.
• Some suggest vascular/endothelial impacts, inflammation, and metabolic changes (weight gain, “munchies,” metabolic syndrome) as plausible contributors.

Route of administration (smoke vs edibles/vapes)

• Repeated criticism that the study and press release do not distinguish smoking from edibles or vaping.
• Many assume inhaling burnt material is independently harmful; others emphasize that edibles also raise heart rate and might stress other organs (e.g., liver).
• Some speculate that null or weaker findings for edibles may be underreported, but this is acknowledged as unclear.

Mental health and subjective experiences

• Numerous reports of cannabis-induced anxiety, panic attacks, derealization/depersonalization, and psychotic-like episodes, especially with high-THC modern products or in those with genetic vulnerability.
• Others say low-dose or high-CBD products can reduce anxiety; experiences vary widely.
• Several describe cannabis as a coping tool for emotional distress, loneliness, or trauma, sometimes clearly worsening long-term outcomes.

Use patterns, lifestyle, and risk context

• Multiple anecdotes from heavy long-term users who report normal cardiac workups, contrasted with stories of serious heart issues arising unexpectedly.
• Some highlight confounding behaviors: poor diet, overeating while high, sedentary habits, co-use of alcohol/cocaine/tobacco.
• Debate over whether heavy users are disproportionately people with pre-existing psychosocial problems vs “healthy, sporty” or high-functioning professionals.

Addiction, quitting, and harm reduction

• Mixed views on dependence: some claim quitting is easy and withdrawal negligible; others describe years-long difficulty and significant psychological or sleep effects.
• Suggested strategies: tapering, replacing habits with exercise, social activities, or other routines; some mention supplements or GLP-1 drugs but with no consensus.

Policy, research, and normalization

• Frustration with Schedule I status slowing rigorous research, inconsistent regulation (e.g., kratom vs cannabis), and commercialization outpacing evidence.
• Some criticize cultural narratives that cannabis is harmless or “healthy,” arguing risks are now being understated, much as smoking once was.
• Others stress that people will continue to seek recreational drugs; the goal should be honest risk communication, not moral panic.